A model of care that is grounded in evidence-based modalities of treatment, which integrates the science of medicine, the art of therapy and the compassion of spirituality into an experience that forges connection to self, others and a sense of meaning and purpose is highly effective in treating persons suffering from substance use disorder.
Preliminary data from researchers at the University of Pittsburgh Medical Center showed that naltrexone reduced both pain and disability in chronic pain patients when administered in low doses, according to a media report.
With funding from a State Opioid Response 2.0 grant, the Ohio Department of Mental Health and Addiction Services will provide access to Pear Therapeutics' reSET and reSET-O digital therapeutics for the treatment of SUD and OUD.
Efforts to Reduce Opioid Prescribing May Be Causing Unintended Consequences for Terminally Ill Patients
Policies aimed at curbing opioid misuse might be limiting access to pain-relieving medications for terminally ill patients, according to research from Oregon State University.